Leigh Syndrome Due to mtDNA Pathogenic Variants

Leigh syndrome is a devastating neurodegenerative disease, typically manifesting in infancy or early childhood. Hallmarks of the disease are symmetrical lesions in the basal ganglia or brain stem on MRI, and a clinical course with rapid deterioration of cognitive and motor functions. It is genetically heterogeneous, causative mutations have been disclosed in mitochondrial DNA and nuclear genes involved in the process of energy production in the mitochondria. We investigated the whole mitochondrial DNA in three Brazilian patients with LS, based on their clinical and biochemical data, with the aim to identify the disease-causing mutations. In two of the patients, with complex I deficiency, a novel heteroplasmic variant m.4142G>T (p.R279L) in MT-ND1 and a recurrent homoplasmic mutation m.10197G>A (p.A47T) in MT-ND3 were identified. In the remaining patient, with complex IV deficiency, a de novo heteroplasmic variant in MT-CO1 m.6547T>C (p.L215P) was found. The molecular investigation in mitochondrial diseases have shifted their focus from mitochondrial DNA to nuclear DNA, however, mtDNA protein-coding genes are one of the important genetic causes of mitochondrial disorders for Leigh syndrome. This study expands the molecular and clinical spectrum associated with this disease.

[1]  C. Bris,et al.  Bioinformatics Tools and Databases to Assess the Pathogenicity of Mitochondrial DNA Variants in the Field of Next Generation Sequencing , 2018, Front. Genet..

[2]  R. Saneto,et al.  The Application of Clinical Genetics Dovepress the Genetics of Leigh Syndrome and Its Implications for Clinical Practice and Risk Management , 2022 .

[3]  J. V. Van Hove,et al.  A new mutation in MT-ND1 m.3928G>C p.V208L causes Leigh disease with infantile spasms. , 2013, Mitochondrion.

[4]  E. Mayatepek,et al.  Teaching NeuroImages: Rapidly progressive leukoencephalopathy in mitochondrial complex I deficiency , 2013, Neurology.

[5]  Li Chieh Chen,et al.  Transition to Next Generation Analysis of the Whole Mitochondrial Genome: A Summary of Molecular Defects , 2013, Human mutation.

[6]  M. Zeviani,et al.  MELAS-like encephalomyopathy caused by a new pathogenic mutation in the mitochondrial DNA encoded cytochrome c oxidase subunit I , 2012, Neuromuscular Disorders.

[7]  Robert W. Taylor,et al.  The clinical spectrum of the m.10191T>C mutation in complex I‐deficient Leigh syndrome , 2012, Developmental medicine and child neurology.

[8]  K. Seong,et al.  Mutational analysis of whole mitochondrial DNA in patients with MELAS and MERRF diseases , 2010, Experimental & Molecular Medicine.

[9]  N. Larsson,et al.  MtDNA mutations are a common cause of severe disease phenotypes in children with Leigh syndrome. , 2009, Biochimica et biophysica acta.

[10]  V. Tiranti,et al.  Identification of novel mutations in five patients with mitochondrial encephalomyopathy. , 2009, Biochimica et biophysica acta.

[11]  J. Finsterer Leigh and Leigh-like syndrome in children and adults. , 2008, Pediatric neurology.

[12]  M. Hirano,et al.  Biochemical and genetic analysis of Leigh syndrome patients in Korea , 2008, Brain and Development.

[13]  M. Zeviani,et al.  Novel mutations of ND genes in complex I deficiency associated with mitochondrial encephalopathy. , 2007, Brain : a journal of neurology.

[14]  I. D. de Coo,et al.  Mutations in the ND5 subunit of complex I of the mitochondrial DNA are a frequent cause of oxidative phosphorylation disease , 2007, Journal of Medical Genetics.

[15]  A. Munnich,et al.  A novel recurrent mitochondrial DNA mutation in ND3 gene is associated with isolated complex I deficiency causing Leigh syndrome and dystonia , 2007, American journal of medical genetics. Part A.

[16]  R. Rodenburg,et al.  Mutated ND2 impairs mitochondrial complex I assembly and leads to Leigh syndrome. , 2007, Molecular genetics and metabolism.

[17]  L. Singh,et al.  Novel mitochondrial mutation in the ND4 gene associated with Leigh syndrome , 2006, Acta neurologica Scandinavica.

[18]  E. Holme,et al.  Two new mutations in the MTATP6 gene associated with Leigh syndrome. , 2005, Neuropediatrics.

[19]  M. Zeviani,et al.  Clinical and molecular findings in children with complex I deficiency. , 2004, Biochimica et biophysica acta.

[20]  D. Turnbull,et al.  Mutations of the mitochondrial ND1 gene as a cause of MELAS , 2004, Journal of Medical Genetics.

[21]  N. Bresolin,et al.  A New Mitochondrial DNA Mutation in ND3 Gene Causing Severe Leigh Syndrome with Early Lethality , 2004, Pediatric Research.

[22]  J. Montoya,et al.  Bilateral striatal necrosis associated with a novel mutation in the mitochondrial ND6 gene , 2003, Annals of neurology.

[23]  G. Comi,et al.  A missense mutation in the mitochondrial ND5 gene associated with a Leigh-MELAS overlap syndrome , 2003, Neurology.

[24]  E. Zimmerman,et al.  Remarkable improvement in adult Leigh syndrome with partial cytochrome c oxidase deficiency , 2003, Neurology.

[25]  Y. Goto,et al.  A novel mtDNA C11777A mutation in Leigh syndrome. , 2003, Mitochondrion.

[26]  M. Hanna,et al.  Is the mitochondrial complex I ND5 gene a hot‐spot for MELAS causing mutations? , 2003, Annals of neurology.

[27]  A. Vighetto,et al.  Leigh‐like encephalopathy complicating Leber's hereditary optic neuropathy , 2002, Annals of neurology.

[28]  Robert W Taylor,et al.  Leigh disease associated with a novel mitochondrial DNA ND5 mutation , 2002, European Journal of Human Genetics.

[29]  Robert W. Taylor,et al.  Progressive mitochondrial disease resulting from a novel missense mutation in the mitochondrial DNA ND3 gene , 2001, Annals of neurology.

[30]  V. Tiranti,et al.  A novel mtDNA mutation in the ND5 subunit of complex I in two MELAS patients , 2001, Annals of neurology.

[31]  R. Carrozzo,et al.  The T9176G mutation of human mtDNA gives a fully assembled but inactive ATP synthase when modeled in Escherichia coli , 2000, FEBS letters.

[32]  S. Dimauro,et al.  G8363A Mutation in the Mitochondrial DNA Transfer Ribonucleic Acid Lys Gene: Another Cause of Leigh Syndrome , 2000, Journal of child neurology.

[33]  V. Tiranti,et al.  A novel frameshift mutation of the mtDNA COIII gene leads to impaired assembly of cytochrome c oxidase in a patient affected by Leigh-like syndrome. , 2000, Human molecular genetics.

[34]  S. Dimauro,et al.  The mitochondrial DNA A3243G mutation in Portugal: clinical and molecular studies in 5 families , 1999, Journal of the Neurological Sciences.

[35]  S. Dimauro,et al.  Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS. , 1997, Biochemical and biophysical research communications.

[36]  S. Dimauro,et al.  Maternally inherited encephalopathy associated with a single‐base insertion in the mitochondrial tRNATrp gene , 1997, Annals of neurology.

[37]  N. Howell,et al.  Association of the mitochondrial 8344 MERRF mutation with maternally inherited spinocerebellar degeneration and Leigh disease , 1996, Neurology.

[38]  Dominic Thyagarajan,et al.  A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis , 1995, Annals of neurology.

[39]  D. Wallace,et al.  A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[40]  F. Gabreëls,et al.  A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome , 1993, Annals of neurology.

[41]  S. Tsuji,et al.  A common mitochondrial DNA mutation in the t-RNA(Lys) of patients with myoclonus epilepsy associated with ragged-red fibers. , 1990, Biochemistry international.

[42]  A. Harding,et al.  A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. , 1990, American journal of human genetics.

[43]  D. Leigh SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY IN AN INFANT , 1951, Journal of neurology, neurosurgery, and psychiatry.